Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
June 1, 2026 8:31 AM EDT
Edgewise Therapeutics Inc. (NASDAQ: EWTX) announced it entered into a definitive agreement to sell sevasemten and its muscular dystrophy business to Servier for $1.55 billion in upfront cash consideration and up to $1.1 billion in additional milestone payments.
Under the agreement, Servier will acquire all rights to sevasemten, including intellectual property, regulatory filings, and clinical data. Edgewise employees primarily supporting... More
June 1, 2026 8:30 AM EDT
Servier announced an agreement to acquire the muscular dystrophy business of Edgewise Therapeutics Inc. (NASDAQ: EWTX) for up to $2.65 billion. The transaction includes an upfront payment of $1.55 billion and up to $1.1 billion in regulatory and commercial milestone payments.
The acquisition includes sevasemten, an investigational oral treatment for Becker and... More
